Taxus Cardium Pharm Group Inc (fka CRXM)

[funnyG986]

CXRM ging to see SEC filings to get back to current

Under the Preferred Stock Purchase Agreement, Gene Biotherapeutics also agreed to use its best efforts to become current in its reporting obligations under the Securities Exchange Act of 1934, as amended. The company has engaged its independent public accounting firm to complete its outstanding audits to insure compliance with SEC regulations.

In connection with the transaction, Gene Biotherapeutics has made changes to its Board of Directors and executive officers.